U.S. Retail Distributors Stock News

Immunome (IMNM) announced its third-quarter and nine-month financial results, revealing a reduced net loss compared to the previous year. Investors are watching how these numbers might shape the company's outlook in the coming months. See our latest analysis for Immunome. Following the earnings release, Immunome’s share price has shown sharp momentum, with a 1-day gain of 5.78% and a remarkable 90-day share price return of 80.94%. While recent quarters have brought their share of challenges,...

Trade Desk (TTD) just posted third quarter earnings that topped expectations and bumped up its revenue forecast for the next quarter. However, the company still faces some headwinds from slowing growth and intensifying competition. See our latest analysis for Trade Desk. Trade Desk’s strong Q3 results and its new revenue target sparked some optimism, but recent events, including an accelerated share buyback, have not stopped the slide in performance metrics. The company’s share price is now...

Unfortunately for some shareholders, the Yatsen Holding Limited ( NYSE:YSG ) share price has dived 35% in the last...

The U.S. stock market has recently experienced a downturn, with major indices like the Dow Jones, S&P 500, and Nasdaq all declining due to concerns over AI-related valuations and strategic corporate partnerships. In this environment of uncertainty, growth companies with high insider ownership can offer a unique advantage as they often indicate strong confidence from those who know the business best.

As the U.S. market experiences a downturn with major indexes like the Dow Jones dropping significantly, investors are seeking opportunities that can weather current uncertainties. Penny stocks, though an older term, remain relevant for those looking to invest in smaller or newer companies that might offer unique growth prospects. By focusing on penny stocks with strong financial health, investors can potentially uncover hidden gems amidst market volatility.

Unfortunately for some shareholders, the Magnite, Inc. ( NASDAQ:MGNI ) share price has dived 25% in the last thirty...

Wondering if Madrigal Pharmaceuticals could be a smart buy at today's prices? You are not alone, especially with so much market chatter about where it's really worth putting your money right now. The stock has been on a serious roll, jumping 11.6% in the last week, 26.1% over the past month, and an eye-catching 76.4% year to date. This has culminated in an impressive 82.4% rally over the past year. Much of this momentum came after Madrigal received FDA approval for its liver disease drug,...

Biogen Inc. and Stoke Therapeutics recently announced the publication of final results from the two-year BUTTERFLY natural history study in Dravet syndrome, highlighting the persistent developmental and seizure challenges faced by children and adolescents despite current treatments. This research not only underscores the urgent unmet need for disease-modifying therapies but also validates the relevance of primary and secondary endpoints in Stoke's ongoing Phase 3 EMPEROR trial for...

Alliant Energy Corporation recently announced its third-quarter 2025 earnings, reporting year-over-year revenue growth to US$1.21 billion, but a decrease in quarterly net income to US$281 million, alongside a narrowed 2025 earnings forecast and an increase in 2026 dividend guidance. An interesting insight is that despite higher revenues and a raised dividend target, a sharp increase in short interest suggests heightened investor scrutiny and mixed expectations about the company’s future...

International Paper (IP) has experienced a steady slide in its share price over the past month, with the stock down more than 21% during this period. Investors watching the packaging and paper giant are now weighing what this drop could mean for future valuations and market sentiment. See our latest analysis for International Paper. The recent slide for International Paper comes after a generally tough year, with a share price return of -31% year-to-date and a total shareholder return of -34%...

Ever wondered if Hubbell’s current share price actually lines up with its real value? If you’re weighing up whether now is the time to buy in or hold off, you’re in the right place. After racing to new highs earlier in the year, Hubbell’s shares have pulled back in the short term, with a 9.0% dip this week and essentially flat performance so far in 2024. Several analyst upgrades and sector-wide optimism about U.S. infrastructure spending have put the spotlight on Hubbell lately, fueling both...

Janux Therapeutics reported a net loss of US$24.31 million for the third quarter of 2025, an improvement from the US$28.06 million loss in the same period last year, alongside updates on continued progress in its oncology pipeline. Heightened interest centered on Janux’s prostate cancer program, as early clinical data for T cell-engaging therapies JANX007 and JANX008 indicated improved efficacy and durable responses, prompting renewed analyst confidence ahead of the expected mature Phase 1...

Lendway, Inc.'s ( NASDAQ:LDWY ) earnings announcement last week was disappointing for investors, despite the decent...

Unsurprisingly, AngloGold Ashanti plc's ( NYSE:AU ) stock price was strong on the back of its healthy earnings report...

Synchrony Financial (SYF) shares have seen some movement recently, prompting investors to take a closer look at the company’s financials and how the stock has been performing over the past month. For those following the U.S. credit card and consumer finance sector, it is a name worth tracking. See our latest analysis for Synchrony Financial. Synchrony Financial’s recent pullback comes after an otherwise solid period, with its share price now at $70.47. While the stock faced a modest dip in...

Earlier in November 2025, Carpenter Technology Corporation announced a US$700 million private offering of 5.625% senior notes due 2034, with plans to redeem or repay existing higher-interest debt and support general corporate activities. This debt refinancing positions Carpenter Technology to lower its interest costs and enhance financial flexibility as it continues serving critical sectors like aerospace, defense, and medical markets. We'll explore how this strengthened financial footing...

Terns Pharmaceuticals reported third quarter 2025 results, showing a net loss of US$24.64 million, and announced senior management presented at the Jefferies Global Healthcare Conference in London on November 17, 2025. This combination of financial reporting and prominent conference participation signals the company’s ongoing efforts to build visibility around its oncology pipeline, including its lead program in chronic myeloid leukemia. We'll explore how growing analyst confidence and the...

Mid-America Apartment Communities (MAA) shares have seen movement recently, sparking interest among investors tracking the real estate sector. The stock's year-to-date performance has dipped 15%, prompting conversations about long-term value and potential future upside. See our latest analysis for Mid-America Apartment Communities. Mid-America Apartment Communities’ share price has slipped around 15% year-to-date, reflecting fading momentum as investor sentiment remains cautious, despite...

Despite an already strong run, Apyx Medical Corporation ( NASDAQ:APYX ) shares have been powering on, with a gain of...

Ibotta, Inc.'s ( NYSE:IBTA ) price-to-earnings (or "P/E") ratio of 8x might make it look like a strong buy right now...

Millicom International Cellular reported third-quarter 2025 results showing net income of US$195 million on sales of US$1.42 billion, with strong improvements in earnings per share compared to the same period last year. Operating performance benefited from recent acquisitions in Uruguay and Ecuador, and financial results exceeded expectations for both the quarter and year-to-date periods. We'll examine how Millicom's sharply higher profitability and recent acquisitions could reshape its...

SuperX AI Technology Limited has announced that Dr. Chenhong Huang will become Chairman of the Board, Executive Director, and CEO effective December 1, 2025, bringing with him over 30 years of leadership across major global technology firms. This leadership transformation aligns with SuperX's ambitions to scale its modular AI factory and expand proprietary infrastructure solutions on a global stage. We'll explore how Dr. Huang’s extensive experience in scaling complex technology operations...

Air Products and Chemicals (APD) just released its quarterly earnings, revealing a slight dip in revenue compared to last year. The results reflected softer helium demand as well as the absence of a one-time LNG sale. See our latest analysis for Air Products and Chemicals. Shares of Air Products and Chemicals have lost momentum in 2024, sliding to $253.09 after a turbulent stretch. While the company’s recent quarter was weighed down by softer helium demand, its long-term total shareholder...

Earlier this month, Soleno Therapeutics announced a US$100 million accelerated share repurchase agreement with Jefferies LLC after reporting a net income of US$26.01 million for the third quarter of 2025, reversing a significant loss from the prior year. This announcement came amid increasing scrutiny from law firms investigating Soleno’s disclosures about its VYKAT XR drug following concerns around trial outcomes and adverse events. We'll explore how the emergence of legal investigations...